• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Rezolute Inc (NQ: RZLT )

    5.580 -0.140 (-2.45%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Rezolute Inc

    < Previous 1 2 3 4 5 Next >
    Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
    From Rezolute, Inc.
    Via GlobeNewswire
    Rezolute to Participate in Upcoming Investor Conferences
    From Rezolute, Inc.
    Via GlobeNewswire
    Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
    From Rezolute, Inc.
    Via GlobeNewswire
    FDA Gives Green Signal To Rezolute's Genetic Disorder Treatment
    FDA lifts clinical hold on Rezolute's RZ358 for treating congenital hyperinsulinism, allowing U.S. participants in Phase 3 study. Enrollment expected to start in 2025 with topline data by mid-year. 
    Via Benzinga
    Exposures Product Safety
    FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study
    Commencing study startup activities in the U.S.; participant enrollment anticipated in early 2025 
    From Rezolute, Inc.
    Via GlobeNewswire
    Rezolute to Participate in Upcoming Investor Conferences
    From Rezolute, Inc.
    Via GlobeNewswire
    Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
    From Rezolute, Inc.
    Via GlobeNewswire
    Rezolute to Participate in the BTIG Virtual Biotechnology Conference
    From Rezolute, Inc.
    Via GlobeNewswire
    Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
    Additional $6.7M in funding resulting in approximately $67M in gross proceeds 
    From Rezolute, Inc.
    Via GlobeNewswire
    Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds
    From Rezolute, Inc.
    Via GlobeNewswire
    Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning! 
    Via InvestorPlace
    Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday
    Via Benzinga
    RH Posts Mixed Q1 Results, Joins MSC Industrial Direct And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants
    From Rezolute, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
    From Rezolute, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Rezolute to Participate in the Jefferies Global Healthcare Conference
    From Rezolute, Inc.
    Via GlobeNewswire
    Why Urban Outfitters Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Is Small-Cap Metabolic-Focused Rezolute Stock Trading Higher On Wednesday?
    Rezolute announced topline results from the Phase 2 study of RZ402 for diabetic macular edema, showing significant improvements in macular edema and a favorable safety profile. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Pre-market stock movers are worth checking out on Wednesday as we offer up all the latest news sending shares higher and lower this morning! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)
    From Rezolute, Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.